BRAINTREE, Mass., Feb. 22 /PRNewswire-FirstCall/ -- On January 27, 2010 the FDA cleared the Haemonetics 510(k) for its expanded nomogram to collect two Red Blood Cells on the Cymbal(R) Automated Blood Collection System from female donors who are at least 150 pounds and are 63 inches in height. The Cymbal is a small, portable, battery operated instrument that automates blood collection from volunteer donors, improving process control and helping alleviate blood shortages.
Haemonetics is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com .
CONTACT: Bryanne Salmon of Haemonetics, +1-781-356-9613,
bsalmon@haemonetics.com
Web site: http://www.haemonetics.com/
